Should we abandon corticosteroids during septic shock? No

Current Opinion in Critical Care

Volumn 14, Issue 4, 2008, Pages 384-389

  Groeneveld, Arie Bastiaan Johan ^a   Molenaar, Nienke ^a   Beishuizen, Bert ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Corticosteroids; Hydrocortisone; Relative adrenal insufficiency; Sepsis

Indexed keywords

CORTICOTROPIN; ETOMIDATE; FLUDROCORTISONE; HYDROCORTISONE; METHYLPREDNISOLONE; METYRAPONE; PLACEBO; PREDNISOLONE; CORTICOSTEROID;

ADRENAL INSUFFICIENCY; ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MECHANISM; DRUG WITHDRAWAL; HEMODYNAMICS; HUMAN; HYPERGLYCEMIA; INFECTION RISK; INTENSIVE CARE UNIT; MORTALITY; MYOPATHY; REVIEW; SEPTIC SHOCK; SUPERINFECTION; SURVIVAL; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; HOSPITALIZATION; PATHOPHYSIOLOGY;

ADRENAL CORTEX HORMONES; ADRENAL INSUFFICIENCY; HUMANS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

EID: 50349096749     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e328306a01d     Document Type: Review

References (36)

1. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327.
2. Annane D,Sebille V, CharpentierC, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871.
3. De Jong M, Beishuizen A, Groeneveld ABJ. Defining relative adrenal insufficiency in the critically ill: the ACTH test revisited. In: Vincent JL, editor. Yearbook in intensive care and emergency medicine. Berlin: Springer; 2006. pp. 539-552.
4. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124.
5. Aneja R, Carcillo JA. What is the rationale for hydrocortisone treatment in children with infection-related adrenal insufficiency and septic shock? Arch Dis Child 2007; 92:165-169.
6. Morel J, Venet C, Donati Y, et al. Adrenal axis function does not appear to be associated with hemodynamic improvement in septic shock patients systematically receiving glucocorticoid therapy. Intensive Care Med 2006; 32:1184-1190.
7. Raurich JM, Llompart-Pou JA, Ibañez J, et al. Low-dose steroid therapy does not affect hemodynamic response in septic shock patients. J Crit Care 2007; 22:324-330.
8. Riche FC, Boutron CM, Valleur P, et al. Adrenal response in patients with septic shock of abdominal origin: relationship to survival. Intensive Care Med 2007; 33:1761 -1766.
9. Annane D, Maxime V, Ibrahim F, et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006; 174:131 9-1326.
10. Bollaert PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-650.
11. Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732.
12. Yildiz O, Doganay M, Aygen B, et al. Physiological-dose steroid therapy in sepsis. Crit Care 2002; 6:251 -258.
13. Keh D, Boehnke T, Weber-Cartens S, et al. Immunologic and hemodynamic effects of low dose hydrocortisone in septic shock: a double blind, randomized, placebo-controlled, crossover study. Am J Resp Crit Care Med 2003; 167:512-520.
14. Oppert M, Schindler R, Husung C, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine level in early hyperdynamic septic shock. Crit Care Med 2005; 33:2457-2464.
15. de Jong MFC, Beishuizen A, Spijkstra JJ, Groeneveld ABJ. Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock. Crit Care Med 2007; 35:1896-1903.
16. Fernández J, Escorse A, Zabalza M, et al. Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival. Hepatology 2006; 44:1288-1295.
17. Annane D, Bellisant E, Bollaert PE, et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. Br Med J 2004; 329:480-489.
18. Cotton BA, Guillamondegui OD, Fleming SB, et al. Increased risk of adrenal insufficiency following etomidate exposure in critically ill patients. Arch Surg 2008; 143:62-67.
19. Aberdein J, Singer M. Clinical review: a systematic review of corticosteroid use in infections. Crit Care 2006; 10:203.
20. Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med 2002; 347:1770-1782.
21. van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2003: CD004405. DOI: 10.1002/14651858.CD004405.pub2
22. Mai NTH, Chau TTH, Thwaites G, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med 2007; 357:2431-2440.
23. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia. A preliminary randomized study. Am J Respir Crit Care Med 2005; 171:242-248.
24. Huang CJ, Lin HC. Association between adrenal insufficiency and ventilator weaning. Am J Respir Crit Care Med 2006; 173:276-280.
25. Halonen J, Halonen P, Järvinen O, et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA 2007; 297:1562-1567.
26. Aouifi A, Piriou V, Bastien O, et al. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 2000; 28:3171-31 76.
27. Winter W, Kamolz L, Donner A, et al. Hydrocortisone improved haemody-namics and fluid requirements in surviving but not nonsurviving of severely burned patients. Burns 2003; 29:717-720.
28. Fuchs PCH, Bopzkurt A, Johnen D, et al. Beneficial effect of corticosteroids in catecholamine-dependent septic burn patients. Burns 2006; 33:306-311.
29. Meduri GU, Marik PE, Chrousos GP, et al. Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med 2008; 34:61 -69.
30. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS. Results of a randomized controlled trial. Chest 2007; 131:954-963.
31. Annane D, Sebille V, Bellisant E, for the Ger-Inf-05 Study group. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006; 34:22-30.
32. Yang S, Zhang L Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2004; 2:1 -12.
33. Britt RC, Devine A, Swallen KC, et al. Corticosteroid use in the intensive care unit. At what cost? Arch Surg 2006; 141:145-149.
34. Schweickert WD, Hall J. ICU-acquired weakness. Chest 2007; 131:1541-1549.
35. Loisa P, Parviainen I, Tenhunen J, et al. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial. Crit Care 2007; 11:R21.
36. Rady MY, Johnson DJ, Patel B, et al. Corticosteroids influence the mortality and morbidity of acute critical illness. Crit Care 2006; 10:1-9.